Trial NCT04589832

View at ClinicalTrials.gov 
Org. Study IDs: MEL18-372

Last trial update was posted on 2023-11-22

MeSH Interventions

Entrectinib

MeSH Conditions

Melanoma Uveal Neoplasms

Other Conditions

Uveal Melanoma

Stopping Reasons

This study required dose reductions to the lower dose level (Dose level -1). But this dose level (Dose level -1) was not further explored because of lack of funding.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID